Diagnostic Approach for Mitochondrial Cytopathy

Initial Laboratory Evaluation

Complete blood count should be performed to detect potential cytopenias or thrombocytopenia that may be associated with mitochondrial disorders, as part of the initial laboratory evaluation for patients with suspected mitochondrial cytopathy, according to Praxis Medical Insights 1
Basic metabolic panel including calcium, magnesium, and creatinine should be assessed to evaluate organ function and electrolyte abnormalities in patients with suspected mitochondrial cytopathy, as recommended by Praxis Medical Insights 1
Glucose metabolism tests, such as fasting glucose and HbA1c, should be included as mitochondrial disorders can affect glucose regulation, as noted by Praxis Medical Insights 1
Thyroid function tests, including TSH, are recommended to screen for thyroid dysfunction which can occur in mitochondrial disorders, as suggested by Praxis Medical Insights 1
Lipid profile should be obtained as dyslipidemia is common in mitochondrial disorders, according to Praxis Medical Insights 1

Whole exome sequencing should be considered as a first or second-tier test in patients with suspected mitochondrial disorders, particularly when clinical presentation is complex, as recommended by the Annals of Neurology 2
For patients with clinical features strongly suggestive of specific mitochondrial syndromes, targeted genetic testing for known pathogenic variants may be appropriate before proceeding to broader genomic analysis, as suggested by the Annals of Neurology 2

Basic metabolic panel, CBC, thyroid function, and lipid profile should be included in first-tier testing for patients with suspected mitochondrial cytopathy, as recommended by Praxis Medical Insights 1
Consider whole exome sequencing as an early diagnostic test, particularly with strong clinical suspicion, as suggested by the Annals of Neurology 2

Using standard reference ranges without considering disease-specific normative data can lead to misinterpretation of test results in patients with mitochondrial cytopathy, as noted by Praxis Medical Insights 1
Neglecting to monitor for common comorbidities like diabetes and dyslipidemia can impact patient care in mitochondrial disorders, as recommended by Praxis Medical Insights 1